Company.
We are a mechanotherapeutics company with a focus on Active Human Collagen
About Us
BrilliantStrings Therapeutics has developed an Activated Collagen biomaterial capable of repairing injured or degenerated connective tissue (e.g. rotator cuff, meniscus, ACL, tendinopathy) and wounds. Activated Collagen can dramatically improve healing, reduce recovery time, and strengthen the injured tissue.
Cost-Effective AHC Production
Massive amplification of human cell production of AHC via CRISPR. Patent filed.
Stable Active Collagen Packaged for Delivery
Proprietary liquid-crystal packaging protects activated collagen and controllably delivers it to injury. Patent Filed.Science.
Our science tells us that delivering ACTIVE Collagen will improve outcomes!
Injury Targeting
Collagen molecules “home” to injury caused by enzyme or mechanical damage.
Self-Healing
Mechanical force “causes” the assembly of collagen fibers that then resists the force that caused them.
Enhanced Cell Healing
Exogenously added collagen molecules (red and green labelled) self-incorporate into matrix produced by human cells.
Team.
BrilliantStrings Founders.
Jeff Ruberti, Ph.D.
CEO
Professor of Bioengineering
Northeastern University
Fellow AIMBE 2022
Luke Oh, M.D.
Consultant Surgeon
Orthopedic Surgeon
Mass General Hospital
Harvard Medical School
JJ Paten, Ph.D.
Chief Scientist
Lecturing Faculty
Mechanical Engineering
Harvard University
Scott Weiss, MBA
Chief Operations
Business Founder
Jackson Oakmont LLC
Author
Shubhro Sen, Ph.D.
Chief Strategist
Led Multiple entities to IPO’s/exits
D’Amore McKim School of Business
Northeastern University
Contact.
Learn more about our technology.